DocDollars

Lexicon Pharmaceuticals, Inc.

TX · United States · Reporting entity ID 100000181746

Total reported 2019–2025
$28.9M
#248 of 2,960 reporting companies — 0% of all reported industry payments
$4.20M in general payments across 38,266 records, plus $24.7M in research funding across 2,861 records.

How it breaks down

General payments $4,199,859
Research funding $24,669,968

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Lexicon Pharmaceuticals, Inc. reported $28.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #248 of 2,960 reporting companies. 85% of that was research funding and 15% general payments such as consulting, speaking, food and travel. 38,266 general payment records and 2,861 research records were filed.

Common questions about Lexicon Pharmaceuticals, Inc.

How much has Lexicon Pharmaceuticals, Inc. paid US doctors?

Lexicon Pharmaceuticals, Inc. reported $28,869,827 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,199,859 in general payments, $24,669,968 in research funding.

How does Lexicon Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #248 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Lexicon Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.